Cargando…

Perspectives on the Designation of Oligonucleotide Starting Materials

The designation of starting materials (SMs) for pharmaceuticals has been a topic of great interest and debate since the first ICH quality guidance was published. The increase in the number and variety of commercialized oligonucleotides (antisense oligonucleotides—ASOs, small interfering RNAs—siRNAs,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiesman, William F., McPherson, Andrew K., Diorazio, Louis J., Van den Bergh, Leo, Smith, Peter D., Northall, John M., Fettes, Alec, Wang, Tiejun, Mehlmann, Martin, Raza, Syed, Held, Gary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2021
Materias:	Issues in Development
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997719/ https://www.ncbi.nlm.nih.gov/pubmed/33534646 http://dx.doi.org/10.1089/nat.2020.0909

Ejemplares similares

Molecular Mechanisms of Antisense Oligonucleotides
por: Crooke, Stanley T.
Publicado: (2017)

Technical Considerations for Use of Oligonucleotide Solution API
por: Muslehiddinoglu, Jale, et al.
Publicado: (2020)

Considerations for the Terminal Sterilization of Oligonucleotide Drug Products
por: DeCollibus, Daniel Paul, et al.
Publicado: (2023)

Guidelines for Experiments Using Antisense Oligonucleotides and Double-Stranded RNAs
por: Gagnon, Keith T., et al.
Publicado: (2019)

OSWG Recommended Approaches to the Nonclinical Pharmacokinetic (ADME) Characterization of Therapeutic Oligonucleotides
por: Berman, Cindy L., et al.
Publicado: (2023)

Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives
por: Synofzik, Matthis, et al.
Publicado: (2022)

Considerations of the Japanese Research Working Group for the ICH S6 & Related Issues Regarding Nonclinical Safety Assessments of Oligonucleotide Therapeutics: Comparison with Those of Biopharmaceuticals
por: Hirabayashi, Yoko, et al.
Publicado: (2021)

What's in a name: the Vermont Genetically Engineered Food Labeling Act
por: McPherson, Malia J.
Publicado: (2014)

Evaluation and Reduction of CRISPR Off-Target Cleavage Events
por: Vakulskas, Christopher A., et al.
Publicado: (2019)

On Mammalian Totipotency: What Is the Molecular Underpinning for the Totipotency of Zygote?
por: Hu, Kejin
Publicado: (2019)

FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2017)

Experimental Model Systems Used in the Preclinical Development of Nucleic Acid Therapeutics
por: Zhou, Haiyan, et al.
Publicado: (2023)

Sustainability Challenges and Opportunities in Oligonucleotide Manufacturing
por: Andrews, Benjamin I., et al.
Publicado: (2020)

Enhancing health literacy through co-design: development of culturally appropriate materials on genetic risk and customary consanguineous marriage
por: Ali, Parveen Azam, et al.
Publicado: (2018)

523 The Development of an Institutional Study Start-up Tracker for Industry Sponsored Clinical Trials
por: Jones, Derek, et al.
Publicado: (2022)

An interaction that gets things started
por: Dove, Alan W.
Publicado: (2003)

Selecting synapse start sites
por: Dove, Alan W.
Publicado: (2002)

How to start a motor
por: Dove, Alan W.
Publicado: (2002)

Jump-starting tumor-specific T cells
por: Van Epps, Heather L.
Publicado: (2005)

When death starts with a caspase
por: Dove, Alan W.
Publicado: (2003)

Processes and determinants of integration of eGFR in physicians’ drug prescriptions: a qualitative study of semi-structured interviews
por: Lefèvre, Louis, et al.
Publicado: (2019)

The Low Energy Antiproton Ring (LEAR) some months before the start of its particle physics programme
Publicado: (1983)

The Low Energy Antiproton Ring (LEAR) some months before the start of its particle physics programme
Publicado: (1983)

Recruiting patients and collecting data for an observational study using computerised record pop-up prompts: the PROG-RES study
por: Hayward, Richard A., et al.
Publicado: (2012)

The Continuum of Comparability Extends to Biosimilarity: How Much Is Enough and What Clinical Data Are Necessary?
por: McCamish, M, et al.
Publicado: (2013)

Improving capacity in ethnicity and health research: report of a tailored programme for NHS Public Health practitioners
por: Salway, Sarah, et al.
Publicado: (2012)

The Signature Program: Bringing the Protocol to the Patient
por: Kang, BP, et al.
Publicado: (2015)

Families First: the development of a new mentalization-based group intervention for first-time parents to promote child development and family health
por: Kalland, Mirjam, et al.
Publicado: (2015)

Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease
por: Cummings, J, et al.
Publicado: (2015)

Digital technologies for cognitive assessment to accelerate drug development in Alzheimer's disease
por: Leurent, C, et al.
Publicado: (2015)

Potential Psychiatric Uses for MDMA
por: Yazar‐Klosinski, BB, et al.
Publicado: (2017)

Harnessing the Power of Real‐World Evidence (RWE): A Checklist to Ensure Regulatory‐Grade Data Quality
por: Miksad, Rebecca A., et al.
Publicado: (2017)

Bedside to Bench: Integrating Quantitative Clinical Pharmacology and Reverse Translation to Optimize Drug Development
por: Gibbs, John P., et al.
Publicado: (2017)

Development of Molecularly Targeted Therapies to Treat Pediatric Malignancies
por: Stewart, Clinton F., et al.
Publicado: (2017)

Does characterising patterns of multimorbidity in stroke matter for developing collaborative care approaches in primary care?
por: Aquino, Maria Raisa Jessica (Ryc) V, et al.
Publicado: (2019)

Substance misuse in later life: challenges for primary care: a review of policy and evidence
por: Rao, Rahul, et al.
Publicado: (2019)

Access to care of frail community-dwelling older adults in Belgium: a qualitative study
por: Fret, Bram, et al.
Publicado: (2019)

Analysis of evidence appraisals for interventional studies in family medicine using an informatics approach
por: Sahin, Alain Nathan, et al.
Publicado: (2019)

Toward interchangeable biologics
por: McCamish, M, et al.
Publicado: (2015)

Policy proposals for a new welfare: the development of the family and community nurse in Italy as the key to promote social capital and social innovation
por: Marcadelli, Silvia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_821h3912t0vrggnnbn9j4nqmoe